IRCT20241015063373N1 IRCT 2025-01-08 Tabriz University of Medical Sciences Effect of Lavender Essential Oil Formulation on Hair loss Evaluating the Effectiveness of Nanostructured Lipid Carriers Containing Lavender Essential Oil Compared to 2% Minoxidil for Androgenic Hair loss; Clinical Trial 2024-10-31 anticipated 20 Complete https://irct.ir/trial/79732 interventional Randomization: Not randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment. 2-3 Androgenic Alopecia. Intervention 1: Intervention group: In the Intervention Group, Lipid Nanostructure Formulation Containing Lavender Essential Oil will be used. In order to prepare Lipid Nanostructures, a High-speed Homogenization Method is used using a Homogenizer. The Formulation of Lipid Nanostructures Containing Lavender Essential Oil is made in the Laboratory of the Tabriz Faculty of Pharmacy. To prepare this Formulation, 400 mg of Lavender Essential oil as a Liquid Phase, 600 mg of Precirol as a Solid Phase, and 250 mg of Ploxamer as a Surfactant are used. (The Steps of Producing Lipid Nanostructures are briefly written.) Lavender essential Oil contains Compounds that cause the Expression of Factors that Increase Hair Growth and Hair Density. The Intervention Period is 24 weeks, in which 2% Minoxidil Manufactured by Pak Darou Company is used on One Side and a Formulation of Lipid Nanostructures Containing Lavender Essential Oil is used on the Other side at Two Symmetrical Points on the Head. The Desired Formulation will be applied One Night a week in an Amount of 1 cc in a Pre-determined Area of ​​1 cm in Diameter. The necessary Photographs will be taken by Dermatoscope at times Zero, 12 weeks and 24 weeks after the Start, and the Images will be analyzed by the Doctor. Intervention 2: Control group: In the Control group, 2% Minoxidil, a Product of Pak Darou Company, will be used Once daily. 2% minoxidil will be applied once every Night in an Amount of 1 cc in a Pre-determined Area of ​​1 cm in Diameter. The Intervention Period is 24 weeks, and Imaging is performed at times Zero, 12 weeks, and 24 weeks after the Start of the Intervention. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is There is no further information